Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection

Disseminated adenovirus infections (d-ADV) after hematopoietic cell transplant (HCT) are often fatal with limited treatment options. Brincidofovir (BCV) a lipid ester of cidofovir is developed for this indication. We report four pediatric HCT recipients with d-ADV treated successfully with BCV.

Detalles Bibliográficos
Autores principales: Chan, Shuk Ying, Prockop, Susan E., Boulad, Farid, Papanicolaou, Genovefa A., Lee, Yeon Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511378/
https://www.ncbi.nlm.nih.gov/pubmed/32869551
http://dx.doi.org/10.3947/ic.2020.0204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511378/
https://www.ncbi.nlm.nih.gov/pubmed/32869551
http://dx.doi.org/10.3947/ic.2020.0204

Ejemplares similares